Allison W. Kurian, M.D., M.Sc.
Academic Appointments
- Assistant Professor - Med Center Line, Medicine - Oncology
- Member, Stanford Cancer Institute
- Assistant Professor - Med Center Line, Health Research & Policy
Key Documents
Contact Information
-
Clinical Offices
Oncology 875 Blake Wilbur Dr MC 5826 Stanford, CA 94305 Tel Work (650) 498-6000 Fax (650) 498-5150
- Academic Offices
Personal Information Email Tel (650) 498-6000Alternate Contact Oncology Clinic Tel Work 650-498-6000Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Breast Cancer
- Cancer Genetics
- Medical Oncology
- Breast Cancer Risk
Administrative Appointments
- Scientific Program Committee, Cancer Prevention and Epidemiology, American Society of Clinical Oncology (2011 - 2014)
- Planning Committee, Quality Care Symposium, American Society of Clinical Oncology (2011 - present)
- Scientific Program Committee, Genetic and Molecular Epidemiology, American Association for Cancer Research (2011 - present)
- Board of Directors, Santa Clara County, American Cancer Society (2011 - present)
- Panel on Clinical Guideline Development for Genetic Risk of Breast and Ovarian Cancer, National Comprehensive Cancer Network (2009 - present)
Honors and Awards
- Top 12 publications funded by the Epidemiology and Genomics Research Program, National Cancer Institute (2012)
- New Clinical Investigator Award, Stanford Cancer Institute (2011)
- Translational Research Award, California Breast Cancer Research Program (2010)
- Jan Weimer Faculty Investigator Award for Breast Cancer Research, Stanford University (2008)
- Physician Faculty Scholars Award, Robert Wood Johnson Foundation (2008)
Professional Education
| Medical Education: | Harvard Medical School MA (1999) |
| M.Sc.: | Stanford University, Epidemiology (2006) |
| Board Certification: | Medical Oncology, American Board of Internal Medicine (2005) |
| Fellowship: | Stanford University School of Medicine CA (2005) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (2002) |
Postdoctoral Advisees
Community and International Work
Scientific Focus
Current Research Interests
My research focuses on the epidemiology, prevention, and outcomes of women's cancers. This work is highly collaborative within the Stanford Divisions of Oncology and Epidemiology, with the Stanford Departments of Radiology, Obstetrics and Gynecology, Pathology, and Biomedical Informatics, and with the Cancer Prevention Institute of California.
Ongoing projects include studies of racial/ethnic differences in hereditary breast and ovarian cancer, early-phase chemoprevention and treatment trials, and computer-based simulation modeling to evaluate new approaches to cancer screening and prevention.
Clinical Trials
- Factors Influencing Decision-Making About the Use of Chemoprevention in Women at Increased Risk for Breast Cancer Recruiting
- Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples Recruiting
- Phase II Gemcitabine, Carboplatin & PARP Inhibitor BSI-201 in Neoadjuvant Tx of Triple-Neg Breast CA No longer recruiting
- A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer No longer recruiting
- A Randomized Controlled Trial using Novel Markers to Predict Malignancy in Elevated-Risk Women No longer recruiting
Publications
- Online Tool to Guide Decisions for BRCA1/2 Mutation Carriers. J Clin Oncol. 2012; (5): 497-506
- Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry. J Clin Oncol. 2011; (34): 4505-9
- Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res. 2010; (6): R99
- Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. J Clin Oncol. 2010; (2): 222-31
- Second primary breast cancer occurrence according to hormone receptor status. J Natl Cancer Inst. 2009; (15): 1058-65
Help